Showing results (401-410 of 427) with videos related to

Sort By:
Pageof 43
The American Journal of Pathology|April 1, 1991
Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cellsC Zoja, J M Wang, S Bettoni, et al.
The Journal of Clinical Investigation|September 1, 1985
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosusC Patrono, G Ciabattoni, G Remuzzi, et al.
Blood|July 9, 1999
Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTPM Galbusera, M Noris, C Rossi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2006
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutationJ M Saland, S H Emre, B L Shneider, et al.
Kidney International|March 31, 2006
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAALD de Zeeuw, D Ramjit, Z Zhang, et al.
Kidney International|June 16, 2006
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disordersN Besbas, D Karpman, D Landau, et al.
Transplantation|February 7, 2001
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplantG Dotti, R Fiocchi, T Motta, et al.
Prostaglandins|July 1, 1980
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsiaG Remuzzi, D Marchesi, C Zoja, et al.
The Journal of Clinical Investigation|March 1, 1983
Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defectG Remuzzi, A Benigni, P Dodesini, et al.
The New England Journal of Medicine|November 26, 1998
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndromeM Furlan, R Robles, M Galbusera, et al.
Pageof 43